Claim your company profile
AfterRaise/Today/19 October 2026

AfterRaise daily

19 October 2026 on AfterRaise

14 companies raised $541M in disclosed rounds of $5M or more. Every figure links to its source, and every company page follows what happens next.

14companies raised yesterday LiveNew+27% vs 7-day average65raised in the last 7 days Live-23% vs last week18US expansion signals this month AfterRaise intelligence26companies stated hiring plans this month AfterRaise intelligence1832open roles Public signal
FundingPublic signalyesterday
Nouscom
€120M · Series D · Basel, Switzerland · Biotech & Pharma
What changed

Raised €120M in Series D funding, led by M Ventures and Revelation Partners.

The company said the funding supports advance its lead asset, NOUS-209, through a global, registration-enabling clinical trial for cancer interception in Lynch Syndrome (LS) carriers.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Estuary Biotherapeutics
$93M · Series A · Newton, USA · Biotech & Pharma
What changed

Raised $93M in Series A funding, led by RA Capital Management.

The company said the funding supports support the advancement of its two lead programs, EST-201 and EST-101 to further develop its kidney-targeting platform.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceLicensing and BD partnershipsProduct leadershipDesign partnersSpecialist engineeringClinical operations
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Antheia
$80M · Debt · Menlo Park, USA · Biotech & Pharma
What changed

Raised $80M in Debt funding.

The company said the funding supports support its U.S. manufacturing strategy and onshore the production of key starting materials (KSMs) and active pharmaceutical ingredients (APIs) vital to public health and national security.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringManufacturing capacity expansion
Where help may be relevant AfterRaise intelligenceCMC and manufacturingQuality systemsLicensing and BD partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Microbiotica
£36M · Series C · Cambridge, UK · Biotech & Pharma
What changed

Raised £36M in Series C funding, led by British Business Bank.

The company said the funding supports advance its lead asset, MB310, into Phase 2 clinical development in ulcerative colitis following positive results from its COMPOSER-1 Phase 1b study.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAccelerated hiring across functions
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Holyvolt
$45M · Undisclosed · San Diego, USA · Energy & Climate
What changed

Raised $45M.

The company said the funding supports expand its AI capabilities, laboratory capacity, and scientific team, while advancing its nickel- and cobalt-free DRX cathode materials toward commercial deployment.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsField operationsCertificationIndustrial partnershipsMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
ZAP Surgical Systems
$36M · Undisclosed · San Carlos, USA · Healthcare & Medtech
What changed

Raised $36M, led by Catalio Capital Management.

The company said the funding supports support the global expansion of its platform across academic medical centers, community hospitals, and physician-led practices, as well as scale production capacity to meet global demand.

Likely next AfterRaise intelligenceGlobal market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceQuality systemsProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
RapidCanvas
$29M · Series B · Austin, USA · AI & Data Infrastructure
What changed

Raised $29M in Series B funding, led by Vertex Ventures SEA and India.

The company said the funding supports grow its go-to-market teams, expand its network of private equity and advisory partners, scale its field AI engineering team across the U.S., Brazil, and India, and invest in product development across its platform.

Likely next AfterRaise intelligenceAsia market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Prism Data Tecnologies
$20M · Series A · New York City, USA · Fintech & Insurance
What changed

Raised $20M in Series A funding, led by Story Ventures.

The company said the funding supports accelerate its next phase of enterprise platform growth, expand its computational data infrastructure, invest in its newly launched REFRACT™ artificial intelligence engine, and scale its commercial implementation teams to support mainstream bank deployments.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceBanking partnershipsEnterprise salesData securityFinance hiringMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Origin
$20M · Undisclosed · USA · Other
What changed

Raised $20M, led by Accel and Zacua Ventures.

The company said the funding supports deploy OG-1, its flagship robot, and build out its fleet, support large-scale pilots with customers in the U.S. and Europe-including large drywall finishing contractors in the U.S., with additional pilots scheduled in Germany, Sweden, France and Saudi Arabia-and extend the platform to new interior trades.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringOperational scale
Where help may be relevant AfterRaise intelligenceCommercial leadershipGo-to-market partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Linkener
€8M · Undisclosed · Valencia, Spain · Energy & Climate
What changed

Raised €8M, led by Klima Energy Transition Fund (Alantra's energy transition fund).

The company said the funding supports accelerate the development of its technology and proprietary AI models for energy management, including bill validation, consumption data analytics, and contract optimization, while also pursuing strategic M&A acquisitions to integrate complementary technologies and services.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAcquisitions and consolidation
Where help may be relevant AfterRaise intelligenceGrid and utility partnershipsProject financeIndustrial partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Epicrispr Biotechnologies
$8M · Grant · San Francisco, USA · Biotech & Pharma
What changed

Raised $8M in Grant funding.

The company said the funding supports support the ongoing first-in-human clinical development of EPI-321, its lead investigational epigenetic therapy for facioscapulohumeral muscular dystrophy (FSHD).

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthOperational scale
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Solvera
$6M · Pre-Seed · Oslo, Norway · Property & Construction
What changed

Raised $6M in Pre-Seed funding, led by Seedcamp.

The company said the funding supports expand its building engineering and technology team in Oslo, establish a London office, and accelerate the development of its operating system.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceProject partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsRegulatory and planning
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Stride
£5M · Seed · London, UK · Biotech & Pharma
What changed

Raised £5M in Seed funding.

The company said the funding supports expand its preventative health product tracking range, fund the ongoing development of its multi-source biological age test, and accelerate the commercial launch of its StrideOne membership program for customers in the United States.

Likely next AfterRaise intelligenceUS market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Lightsprint
$6M · Seed · San Francisco, USA · Enterprise Software
What changed

Raised $6M in Seed funding, led by 645 Ventures.

The company said the funding supports expand its enterprise-ready product and grow its engineering and go-to-market teams.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceEnterprise salesRevenue operationsCloud infrastructureCommercial hiringChannel partnerships
Approach preferences not yet specified
Company pageSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.